Gasser R - Search Results

1

Modulation of gene and protein expression by carbon tetrachloride in the rat liver.

Fountoulakis M, de Vera MC, Crameri F, Boess F, Gasser R, Albertini S, Suter L. Fountoulakis M, et al. Among authors: gasser r. Toxicol Appl Pharmacol. 2002 Aug 15;183(1):71-80. doi: 10.1006/taap.2002.9460. Toxicol Appl Pharmacol. 2002. PMID: 12217644

2

Gene expression in two hepatic cell lines, cultured primary hepatocytes, and liver slices compared to the in vivo liver gene expression in rats: possible implications for toxicogenomics use of in vitro systems.

Boess F, Kamber M, Romer S, Gasser R, Muller D, Albertini S, Suter L. Boess F, et al. Among authors: gasser r. Toxicol Sci. 2003 Jun;73(2):386-402. doi: 10.1093/toxsci/kfg064. Epub 2003 Mar 25. Toxicol Sci. 2003. PMID: 12657743

3

Discriminating different classes of toxicants by transcript profiling.

Steiner G, Suter L, Boess F, Gasser R, de Vera MC, Albertini S, Ruepp S. Steiner G, et al. Among authors: gasser r. Environ Health Perspect. 2004 Aug;112(12):1236-48. doi: 10.1289/txg.7036. Environ Health Perspect. 2004. PMID: 15345370 Free PMC article.

4

Proteomic analysis of the cell envelope fraction of Escherichia coli.

Fountoulakis M, Gasser R. Fountoulakis M, et al. Among authors: gasser r. Amino Acids. 2003;24(1-2):19-41. doi: 10.1007/s00726-002-0339-z. Amino Acids. 2003. PMID: 12624733

5

Troglitazone-induced intrahepatic cholestasis by an interference with the hepatobiliary export of bile acids in male and female rats. Correlation with the gender difference in troglitazone sulfate formation and the inhibition of the canalicular bile salt export pump (Bsep) by troglitazone and troglitazone sulfate.

Funk C, Pantze M, Jehle L, Ponelle C, Scheuermann G, Lazendic M, Gasser R. Funk C, et al. Among authors: gasser r. Toxicology. 2001 Oct 5;167(1):83-98. doi: 10.1016/s0300-483x(01)00460-7. Toxicology. 2001. PMID: 11557132

6

Pharmacogenetic analysis of adverse drug effect reveals genetic variant for susceptibility to liver toxicity.

Acuña G, Foernzler D, Leong D, Rabbia M, Smit R, Dorflinger E, Gasser R, Hoh J, Ott J, Borroni E, To Z, Thompson A, Li J, Hashimoto L, Lindpaintner K. Acuña G, et al. Among authors: gasser r. Pharmacogenomics J. 2002;2(5):327-34. doi: 10.1038/sj.tpj.6500123. Pharmacogenomics J. 2002. PMID: 12439739

7

Lack of interaction between tolcapone and tolbutamide in healthy volunteers.

Jorga KM, Fotteler B, Gasser R, Banken L, Birnboeck H. Jorga KM, et al. Among authors: gasser r. J Clin Pharmacol. 2000 May;40(5):544-51. doi: 10.1177/00912700022009161. J Clin Pharmacol. 2000. PMID: 10806608 Clinical Trial.

8

RO4938581, a novel cognitive enhancer acting at GABAA alpha5 subunit-containing receptors.

Ballard TM, Knoflach F, Prinssen E, Borroni E, Vivian JA, Basile J, Gasser R, Moreau JL, Wettstein JG, Buettelmann B, Knust H, Thomas AW, Trube G, Hernandez MC. Ballard TM, et al. Among authors: gasser r. Psychopharmacology (Berl). 2009 Jan;202(1-3):207-23. doi: 10.1007/s00213-008-1357-7. Epub 2008 Oct 21. Psychopharmacology (Berl). 2009. PMID: 18936916

9

Metabolism and excretion of tolcapone, a novel inhibitor of catechol-O-methyltransferase.

Jorga K, Fotteler B, Heizmann P, Gasser R. Jorga K, et al. Among authors: gasser r. Br J Clin Pharmacol. 1999 Oct;48(4):513-20. doi: 10.1046/j.1365-2125.1999.00036.x. Br J Clin Pharmacol. 1999. PMID: 10583021 Free PMC article. Clinical Trial.

10

Use of transgenic cell lines in mechanistic studies of drug metabolism.

Gasser R, Funk C, Matzinger P, Klemisch W, Viger-Chougnet A. Gasser R, et al. Toxicol In Vitro. 1999 Aug-Oct;13(4-5):625-32. doi: 10.1016/s0887-2333(99)00035-1. Toxicol In Vitro. 1999. PMID: 20654526

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,084 results

Search Page